Breast cancer risk in young women and history of selected medical conditions

International Journal of Epidemiology

Volumn 28, Issue 5, 1999, Pages 816-823

  Weiss, Helen A ^a   Brinton, Louise A ^a   Potischman, Nancy A ^a   Brogan, Donna ^b   Coates, Ralph J ^c   Gammon, Marilie D ^d   Malone, Kathleen E ^e   Schoenberg, Janet B ^f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EMORY UNIVERSITY   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f Special Epidemiology Program   (United States)

Author keywords

Breast cancer; Diabetes; Medical history; Ovarian cysts

Indexed keywords

ADULT; ARTICLE; BASAL CELL CARCINOMA; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; ENDOMETRIOSIS; FEMALE; GALLBLADDER DISEASE; HODGKIN DISEASE; HORMONE DETERMINATION; HUMAN; HYPERTENSION; INTESTINE POLYP; MAJOR CLINICAL STUDY; MELANOMA; NORMAL HUMAN; OVARIECTOMY; OVARY CYST; PRIORITY JOURNAL; QUESTIONNAIRE; THYROID CANCER; THYROID DISEASE; UNITED STATES;

ADULT; AGE DISTRIBUTION; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; COMORBIDITY; CONFIDENCE INTERVALS; DIABETES MELLITUS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; HYPERTENSION; INCIDENCE; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; POPULATION SURVEILLANCE; REFERENCE VALUES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; THYROID DISEASES; UNITED STATES;

EID: 0032723298     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/28.5.816     Document Type: Article

References (55)

1. Brinton LA. Ways that women may possibly reduce their risk of breast cancer. J Natl Cancer Inst 1994;86:1371-72.
2. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1995;87:1681-85.
3. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast proliferation and breast cancer risk. Epidemiol Rev 1993;15:17-35.
4. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993;15:48-65.
5. Goldman MB. Thyroid diseases and breast cancer. Epidemiol Rev 1990; 12:16-28.
6. Stoll BA, Secreto G. New hormone-related markers of high risk to breast cancer. Ann Oncol 1992;3:435-38.
7. Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man. N Engl J Med 1978;299:1221-27.
8. Kaaks R. Nutrition, hormones, and breast cancer: Is insulin the missing link? Cancer Causes Control 1996;7:605-25.
9. Mangtani P, Booth M. Epidemiology of endometriosis. J Epidemiol Community Health 1993;47:84-88.
10. Parazzini F, La Vecchia C, Franchesci S, Cecchetti G. Risk factors for endometrioid, mucinous and serous benign ovarian cysts. Int J Epidemiol 1989;18:108-12.
11. Moseson M, Koenig ML, Shore RE, Pasternack BS. The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 1993;22:1000-09.
12. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47.
13. Horn-Ross PL. Multiple primary cancers involving the breast. Epidemiol Rev 1993;15:169-76.
14. Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut 1935-1982. Natl Cancer Inst Monogr 1985;68:99-112.
15. Schoen RE, Weissfeld JL, Kuller LH. Are women with breast, endometrial or ovarian cancer at increased risk for colorectal cancer? Am J Gastroenterol 1994;89:835-42.
16. Thompson WD, Jacobson HI, Negrini B, Janerich DT. Hypertension, pregnancy and risk of breast cancer. J Natl Cancer Inst 1989;81: 1571-74.
17. Kritchevsky SB, Kritchevsky D. Serum cholesterol and cancer risk: an epidemiologic perspective. Ann Rev Nutr 1992;12:391-416.
18. Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C. Selected medical conditions and risk of breast cancer. Br J Cancer 1997;75:1699-703.
19. Franchesci S, La Vecchia C, Negri E, Parazzini F, Boyle P. Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 1990;26:781-85.
20. Land CE, Hayakawa N, Machado SG et al. A case-control interview study of breast cancer among Japanese A-bomb survivors. I. Main effects. Cancer Causes Control 1994;5:157-65.
21. Lenfant-Pejovic M, Mlike-Cabanne N, Bouchardy C, Auquier A. Risk factors for male breast cancer: a Franco-Swiss case-control study. Int J Cancer 1990;45:661-66.
22. Thomas DB, Jimenez LM, McTiernan A et al. Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol 1992;135: 734-48.
23. Brinton LA, Daling JR, Liff J et al. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 1995;87:827-35.
24. Stanford JL, Hartge P, Brinton LA, Hoover RN, Brookmeyer R. Factors influencing the age at natural menopause. J Chronic Dis 1987;40: 995-1002.
25. Harris MI, Robbins DC. Prevalence of adult-onset IDDM in the US population. Diabetes Care 1994;17:1337-40.
26. Harlow SD, Linet MS. Agreement between questionnaire data and medical records. Am J Epidemiol 1989;129:233-48.
27. Kehoe R, Wu S-Y, Leske MC, Chylack LT. Comparing self-reported and physician-reported medical history. Am J Epidemiol 1994;139: 813-18.
28. Colditz GA, Martin P, Stampfer MJ et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986;123:894-900.
29. Armitage P, Berry G. Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publications, 1987.
30. Goldman MB, Monson RR, Maloof F. Cancer mortality in women with thyroid disease. Cancer Res 1990;50:2283-89.
31. Brinton LA, Hoffman DA, Hoover R, Fraumeni JF. Relationship of thyroid disease and use of thyroid supplements to breast cancer risk. J Chronic Dis 1984;37:877-83.
32. Hoffman DA, McConahey WM, Fraumeni JF, Kurland LT. Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol 1982;11:218-24.
33. Lowenfels AB, Domellof L, Lindstrom CG, Bergman F, Monk MA, Sternby NH. Cholelithiasis, cholecystectomy, and cancer: a case-control study in Sweden. Gastroenterol 1982;83:672-76.
34. Adami HO, Meirik O, Gustavsson S, Nyren O, Krusemo UB. Cholecystectomy and the incidence of breast cancer: a cohort study. Br J Cancer 1984;49:235-39.
35. Wysowski DK, Goldberg EL, Comstock GW, Diamond EI. A study of a possible association between breast cancer and gallbladder disease. Am J Epidemiol 1986;123:532-43.
36. Peipins LA, Sandler RS. Epidemiology of colorectal adenomas. Epidemiol Rev 1994;16:273-97.
37. Bremond A, Collett P, Lambert R, Martin JL. Breast cancer and polyps of the colon. Cancer 1984;54:2568-70.
38. Jouin H, Baumann R, Derlon A et al. Is there an increased incidence of adenomatous polyps in breast cancer patients? Cancer 1989;63: 499-603.
39. Rex DK, Sledge GW, Harper PA et al. Colonic adenomas in asymptomatic women with a history of breast cancer. Am J Gastroenterology 1993;88:2009-14.
40. Murray TI, Neugat AI, Garbowski GC et al. Relationship between breast cancer and colorectal adenomatous polyps. Cancer 1992;69:2232-34.
41. Jarrett RJ. Epidemiology and public health aspects of non-insulin dependent diabetes mellitus. Epidemiol Rev 1989;11:151-71.
42. Bruning PF, Bonfrer JMG, Van Noord P et al. Insulin resistance and breast-cancer risk. Int J Cancer 1992;52:511-16.
43. Hankinson SE, Willett WC, Colditz GA et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393-96.
44. Ragozzino M, Melton LJ III, Chu C-P, Palumbo PJ. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 1982;35:13-19.
45. Adami H-O, McLaughlin J, Ekbom A et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991;6:307-14.
46. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995; 6:164-79.
47. Hiatt RA, Friedman GD, Bawol RD, Ury HK. Breast cancer and serum cholesterol. J Natl Cancer Inst 1982;68:885-89.
48. Pernilly Hoyer A, Engholm G. Serum lipids and breast cancer risk: a cohort study of 5207 Danish women. Cancer Causes Control 1992;3: 403-08.
49. Gaard M, Tretli S, Urdal P. Risk of breast cancer in relation to blood lipid: a prospective study of 31 209 Norwegian women. Cancer Causes Control 1994;5:501-09.
50. Knekt P, Reunanen A, Aromaa A, Heliovaara M, Hakulinen T, Hakama M. Serum cholesterol and risk of cancer in a cohort of 39 000 men and women. J Clin Epidemiol 1988;41:519-30.
51. Vatten LJ, Foss OP. Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24 329 Norwegian women. Cancer Res 1990;50:2341-46.
52. Potischman N, McCulloch CE, Byers T et al. Associations between breast cancer, plasma triglycerides, and cholesterol. Nutr Cancer 1991;15:205-15.
53. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997;176:572-79.
54. Prior P, Pope DJ. Hodgkin's disease: subsequent primary cancers in relation to t treatment. Br J Cancer 1988;58:512-17.
55. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993;85:25-31.